Fawad Ali Shah | Neuropharmacology |

Posted on by Neuroscientists

Dr. Fawad Ali Shah | Neuropharmacology | Best Researcher Award

Dr. Fawad Ali Shah,  Prince Sattam bin Abdulaziz University, Saudi Arabia.

Dr. Fawad Ali Shah is an accomplished neuroscientist and pharmacologist whose academic journey began with a Pharm-D from the University of Malakand, Pakistan, and culminated in a Ph.D. in Neuroscience and Pharmacology from Gyeongsang National University, South Korea. With a strong foundation in neuroprotective pharmacology, his doctoral and postdoctoral research has focused on natural therapeutic agents for cerebral ischemia and brain injury. Professionally, he has held key academic roles in Pakistan, South Korea, Canada, and Saudi Arabia, currently serving as an Associate Professor at Prince Sattam Bin Abdulaziz University.

Profile

Scopus

🎓 Early Academic Pursuits

Dr. Fawad Ali Shah embarked on his academic journey with a profound interest in pharmaceutical sciences and neuroscience. He earned his Doctor of Pharmacy (Pharm-D) degree from the University of Malakand, Khyber Pakhtunkhwa, Pakistan, in 2010 with a First Division and a solid 70.88% score. His thesis, which explored ischemic and reperfusion injuries and their clinical implications, laid a strong foundation for his lifelong dedication to the neuropharmacological sciences. Driven by a deeper quest for knowledge, he pursued his Ph.D. at the esteemed Gyeongsang National University (GNU) in South Korea, where he specialized in neuroscience and pharmacology. Graduating with an A+ average in 2017, his doctoral research focused on investigating the neuroprotective effects of natural drug substances in models of cerebral ischemic injury. This blend of clinical insight and experimental pharmacology set the stage for his career in neuropharmacological research.

🧠 Professional Endeavors in Neuroscience

After earning his doctorate, Dr. Shah’s professional journey took a dynamic course across academia and clinical research institutions. He began as a Research Scholar and Lab Coordinator in the Neurobiology and Brain Histology Lab at GNU, deepening his technical expertise in neurohistology and preclinical pharmacology. Following this, he was appointed as Assistant Professor and then promoted to Associate Professor at Riphah Institute of Pharmaceutical Sciences, Riphah International University, Islamabad. His academic ascent continued with two prestigious postdoctoral positions: a lab-based postdoctoral fellowship at Robarts Research Institute, University of Western Ontario, Canada, and another at the University of Toronto. In 2022, he joined Prince Sattam Bin Abdulaziz University, Saudi Arabia, as an Associate Professor in the Department of Pharmacology and Toxicology. His teaching and mentorship roles have nurtured aspiring pharmacists and neuroscientists alike, while his hands-on work as a former Associate Pharmacist at GlaxoSmithKline (GSK) and Biogenics added vital industry experience to his academic pursuits.

🔬 Research Focus and Scientific Contributions

Dr. Shah’s research is anchored in the exploration of neuroprotective strategies, particularly involving natural drug substances in mitigating cerebral ischemia and related neuronal injuries. His scientific endeavors are characterized by a translational approach—bridging preclinical findings with potential therapeutic implications. Through a series of methodical investigations during his Ph.D. and postdoctoral tenures, he contributed to the understanding of ischemic brain injury mechanisms, drug-induced neuroprotection, and histopathological changes associated with brain trauma. He has significantly advanced the neuropharmacology discipline by contributing original research that addresses real-world health challenges, such as stroke and neurodegenerative conditions. His collaborations in Canadian research institutions have further enriched his methodological expertise and international research exposure.

📚 Teaching Excellence and Academic Impact

As a seasoned academic, Dr. Shah has been instrumental in delivering rigorous pharmacology and toxicology curricula to undergraduate and graduate pharmacy students. His dual role as a researcher and educator has empowered students with both theoretical understanding and laboratory proficiency. His mentorship extends beyond the classroom, guiding research projects and helping students build critical thinking in experimental neuroscience. His affiliation with academic institutions in Pakistan, South Korea, and Saudi Arabia demonstrates his global academic influence and his ability to adapt to diverse educational environments. His role in curriculum development and departmental leadership has contributed to the overall elevation of academic standards wherever he has served.

🏅 Recognition and Accolades

Dr. Fawad Ali Shah is an HEC (Higher Education Commission) Approved Supervisor, a recognition that attests to his academic merit and capability to guide M.Phil. and Ph.D. research. His scholarly distinction, demonstrated by first-class academic performance and international postdoctoral achievements, has earned him esteem in both academic and research circles. His involvement with reputed institutions like the University of Toronto and Robarts Research Institute has positioned him among globally recognized neuroscientists contributing to pharmacological innovation and brain research.

🌍 Global Reach and Influence

Dr. Shah’s academic and research footprints span several continents, including Asia, North America, and the Middle East. His international collaborations and transdisciplinary research have helped forge global scientific alliances. Through participation in international conferences, seminars, and research initiatives, he has disseminated key findings in neuropharmacology and inspired academic exchanges. His commitment to ethical and impactful research, along with his cross-border academic contributions, highlights his role as a globally engaged scholar advancing neuroscience for public health benefits.

🔮 Vision, Legacy, and Future Contributions

Looking ahead, Dr. Shah envisions expanding the therapeutic potential of natural compounds in managing neurodegenerative and cerebrovascular diseases. He aspires to establish advanced neuropharmacology labs in collaboration with global research centers to facilitate translational research and innovative drug discovery. His legacy lies in nurturing a new generation of neuroscientists, fostering research with clinical relevance, and strengthening the bridge between pharmaceutical education and neurological care. With a growing portfolio of impactful publications and international engagements, Dr. Shah is poised to remain a leading voice in neurotherapeutics and pharmacological innovation.

Publication

  1. Title: Carvacrol attenuated haloperidol-induced Parkinson’s disease via TNF/NFκβ-NLRP3-mediated pyroptosis
    Author(s): Not listed
    Year: 2025
    Journal: Laboratory Animal Research

 

  1. Title: In Silico molecular docking and molecular dynamic simulation of transferrin coated Phenytoin loaded SLNs with molecular targets of epilepsy
    Author(s): Not listed
    Year: 2025
    Journal: PLOS ONE

 

  1. Title: Carvacrol attenuated myocardial infarction through NLRP3-mediated pyroptosis and mTOR/Nrf2/PPARγ-dependent autophagic signaling
    Author(s): Not listed
    Year: 2025
    Journal: Toxicology and Applied Pharmacology

 

  1. Title: Retraction notice to “Quercetin attenuated ischemic stroke induced neurodegeneration by modulating glutamatergic and synaptic signaling pathways”
    Author(s): Not listed
    Year: 2024
    Journal: Heliyon

 

  1. Title: Ghrelin’s modulation of growth hormone secretagogue receptors in primary glioblastoma and meningioma: A comprehensive in-vitro study
    Author(s): Not listed
    Year: 2025
    Journal: Biochemical and Biophysical Research Communications

 

  1. Title: Corrigendum to “pH-Sensitive Tacrolimus loaded nanostructured lipid carriers for the treatment of inflammatory bowel disease”
    Author(s): Not listed
    Year: 2024
    Journal: European Journal of Pharmaceutics and Biopharmaceutics

 

  1. Title: Punicalagin improves inflammation and oxidative stress in rat model of pelvic inflammatory disease
    Author(s): Not listed
    Year: 2025
    Journal: Natural Product Research

 

  1. Title: Core-shell tablets designed for modified and sequential release of ibuprofen and rabeprazole
    Author(s): Not listed
    Year: 2024
    Journal: International Journal of Pharmaceutics

 

  1. Title: Effect of Bacillus clausii in attenuating symptoms of DSS-induced ulcerative colitis by modulating NFkB pathway and oxidative stress in mice
    Author(s): Not listed
    Year: 2024
    Journal: Clinical and Experimental Pharmacology and Physiology

 

  1. Title: Paroxetine Loaded Nanostructured Lipid Carriers Based In-situ Gel for Brain Delivery via Nasal Route for Enhanced Anti-Depressant Effect: In Vitro Prospect and In Vivo Efficacy
    Author(s): Not listed
    Year: 2024
    Journal: AAPS PharmSciTech

 

🧾 Conclusion

Dr. Fawad Ali Shah stands out as a dedicated researcher, educator, and global academic contributor in the fields of neuroscience and pharmacology. His blend of international experience, pioneering research on natural neuroprotective agents, and commitment to academic excellence underscores his significant role in the advancement of neurotherapeutics. As he continues to inspire future scientists and lead innovative research, his impact will resonate across both the scientific and clinical communities, shaping the future of neurological health and pharmaceutical sciences.

Jing Du | Neuropsychopharmacology | Best Researcher Award

Posted on by Neuroscientists

Prof. Jing Du | Neuropsychopharmacology | Best Researcher Award

Prof. Jing Du, Beijing Anding Hospital affiliated to Capital Medical University, China.

Prof. Jing Du is a distinguished professor, Ph.D. advisor, and accomplished researcher at Beijing Anding Hospital, affiliated with Capital Medical University. With a strong academic foundation, including her B.M. from Beijing University, Health Science Center, and Ph.D. from Rutgers University, she has made significant strides in mental health research. Her work bridges Traditional Chinese Medicine (TCM) and modern neuroscience, focusing on developing innovative drugs for psychiatric disorders. Through groundbreaking research on molecules like cordycepin (3’-dA), Dr. Du has contributed to understanding neuroimmune mechanisms and creating novel therapeutic approaches for treatment-resistant depression and anxiety. Her efforts are shaping the future of mental health care and inspiring new paths in interdisciplinary research.

 

profile

Orcid

🌱 Early Academic Pursuits

Prof. Jing Du embarked on her academic journey with a passion for unraveling the complexities of mental health. She earned her Bachelor of Medicine from the prestigious Beijing University, Health Science Center, and pursued her doctoral studies at Rutgers University, The State University of New Jersey. These foundational years laid the groundwork for her to merge the realms of neuroscience and Traditional Chinese Medicine (TCM), equipping her with a unique perspective to address global mental health challenges.

💼 Professional Endeavors

Currently, Prof. Jing Du serves as a professor and Ph.D. advisor at Beijing Anding Hospital, affiliated with Capital Medical University. She also boasts an illustrious tenure as a translational scientist at the National Institute of Mental Health, NIH, USA. Her career reflects a harmonious blend of academic rigor and clinical expertise, emphasizing innovation in drug development and collaboration with clinicians to improve mental health treatments.

🌿 Contributions and Research Focus

Prof. Du’s research stands at the intersection of neuroscience and TCM. Her work focuses on isolating single molecules from herbal remedies to develop groundbreaking treatments for psychiatric disorders. By identifying drug targets and exploring molecular mechanisms, she bridges traditional wisdom with modern science. Her notable project on cordycepin (3’-dA) demonstrated its rapid antidepressant effects and potential to modulate neuroimmune responses, offering hope for patients with treatment-resistant depression.

🏆 Accolades and Recognition

Prof. Du’s groundbreaking work has earned her recognition in the scientific community, with her studies published in high-impact journals such as Neuropsychopharmacology. Her innovative approaches have set benchmarks in mental health research, particularly her efforts to uncover novel therapeutic mechanisms. Her dedication continues to inspire peers and mentees in the field.

🌍 Impact and Influence

Through her interdisciplinary approach, Dr. Du has significantly influenced both academic and clinical domains. Her research has not only advanced scientific understanding but also paved the way for the integration of TCM into modern psychiatric care. By addressing the unmet needs of patients with mental illnesses, her work has the potential to transform treatment paradigms on a global scale.

💡 Legacy and Future Contributions

Prof. Du envisions a future where the fusion of traditional and modern medicine leads to innovative, effective treatments for psychiatric disorders. Her ongoing research and mentorship ensure that her legacy will continue to inspire new generations of scientists committed to mental health. As a pioneer in her field, she remains a steadfast advocate for holistic and evidence-based approaches to care.

✨ Bridging Science and Humanity

Prof. Jing Du’s work exemplifies a commitment to bridging the gap between scientific discovery and human well-being. Her efforts to develop accessible, impactful treatments reflect her dedication to addressing the global burden of mental health disorders. With every step forward, she embodies the spirit of innovation, compassion, and perseverance, leaving an indelible mark on the world of psychiatric medicine.

📚 Publications

  1. Title: An insightful comparison of the current neuroimmune mechanism(s) with the thoughts of differential syndromes from traditional Chinese medicine for the treatment of MDD
    Authors: Jiyi Xu, Yi Zhang, Lei Li, Xiaodong Zhao, Feilong Huang, Jing Du
    Year: 2025

 

  1. Title: Ganoderic acid A ameliorates depressive-like behaviors in CSDS mice: Insights from proteomic profiling and molecular mechanisms
    Authors: Xu, Jin-jie; Kan, Wei-jing; Wang, Tian-yi; Li, Lei; Zhang, Yi; Ge, Zi-yu; Xu, Ji-yi; Yin, Zi-jia; Feng, Yuan; Wang, Gang et al.
    Year: 2024

 

  1. Title: Quantitative proteomics combined independent PRM analysis reveals the mitochondrial and synaptic mechanism underlying norisoboldine’s antidepressant effects
    Authors: Li, Lei; Kan, Weijing; Zhang, Yi; Wang, Tianyi; Yang, Feng; Ji, Tengfei; Wang, Gang; Du, Jing
    Year: 2024

 

  1. Title: Utilizing plasma drug levels and genetic testing to achieve optimal treatment response in a patient with treatment-resistant schizoaffective disorder
    Authors: Xu, Jin-jie; Xiao, Chunfeng; Pan, Yanli; Tang, Yi-lang; Wang, Mingwan; Li, Sheng; Xie, Gaoming; Du, Jing; Ren, Yanping; Wang, Wei
    Year: 2024

 

  1. Title: Demographic, clinical and biochemical correlates of the length of stay for different polarities in Chinese inpatients with bipolar disorder: A real-world study
    Authors: Wang, Wei; Du, Jing; Li, Sheng; Xie, Gaoming; Xu, Jinjie; Ren, Yanping
    Year: 2023

 

  1. Title: The FXR mediated anti-depression effect of CDCA underpinned its therapeutic potentiation for MDD
    Authors: Li, Haoran; Zhu, Xuequan; Xu, Jinjie; Li, Lei; Kan, Weijing; Bao, Hongkun; Xu, Jiyi; Wang, Weiwei; Yang, Yang; Chen, Pei et al.
    Year: 2023

 

  1. Title: The Dectin-1 Receptor Signaling Pathway Mediates the Remyelination Effect of Lentinan through Suppression of Neuroinflammation and Conversion of Microglia
    Authors: Zhang, Dandan; Jia, Yue; Sun, Xingzong; Li, Haoran; Yin, Min; Li, Hongliang; Dai, Lili; Han, Li; Wang, Lei; Qian, Menghan et al.
    Year: 2022

 

  1. Title: Activation of FXR by ganoderic acid A promotes remyelination in multiple sclerosis via anti-inflammation and regeneration mechanism
    Authors: Jia, Yue; Zhang, Dandan; Li, Haoran; Luo, Shaolei; Xiao, Yuhuan; Han, Li; Zhou, Fuchun; Wang, Chuanyue; Feng, Lei; Wang, Gang et al.
    Year: 2021

 

  1. Title: Ganoderma lucidum polysaccharides ameliorated depression-like behaviors in the chronic social defeat stress depression model via modulation of Dectin-1 and the innate immune system
    Authors: Li, Haoran; Xiao, Yuhuan; Li Han; Jia, Yue; Luo, Shaolei; Zhang, Dandan; Zhang, Ling; Wu, Peng; Xiao, Chunjie; Kan, Weijing et al.
    Year: 2021

 

  1. Title: Interactions Between Adenosine Receptors and Cordycepin (3′- Deoxyadenosine) from Cordyceps Militaris: Possible Pharmacological Mechanisms for Protection of the Brain and the Amelioration of Covid-19 Pneumonia
    Authors: Jing Du; Weijing Kan; Hongkun Bao; Yue Jia; Jian Yang; Hongxiao Jia
    Year: 2021

 

Conclusion

Prof. Jing Du’s career is a testament to the power of integrating traditional knowledge with cutting-edge science. Her impactful research and dedication to addressing mental health challenges highlight her as a pioneer in the field. By fostering collaboration between researchers and clinicians, she is paving the way for transformative advancements in psychiatry. Dr. Du’s legacy lies not only in her scientific contributions but also in her commitment to improving the lives of individuals struggling with mental illness worldwide.